Results 201 to 210 of about 2,143,617 (291)

Left Ventricular Hypertrophy [PDF]

JAMA, 2004
openaire   +1 more source

Dyslipidaemia, Chronic Kidney Disease and Diabetes Mellitus: A Triple Threat to Cardiovascular Health

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Diabetes mellitus (DM) and chronic kidney disease (CKD) frequently coexist and together create a ‘triple threat’ with dyslipidaemia, enhancing the risk for cardiovascular morbidity and mortality. Diabetic kidney disease (DKD) leads to altered lipid metabolism through insulin resistance, inflammation and oxidative stress resulting in an ...
Ann S. Forrest, Priyanka Majety, Stéphanie B. Mayer, Om P. Ganda   +3 more
wiley   +1 more source

Synthetic Fructoborate Administration: Effects on Cardiac Remodeling and Extracardiac Responses in Isoproterenol-Induced Cardiac Hypertrophy. [PDF]

Pharmaceuticals (Basel)
Ortega-Camarillo C, Díaz-Rosas G, Muñiz-Reyes B, Nieto-Lara PL, Cordova-Chavez RI, Bită A, Soriano-Ursúa MA, Saucedo R, Ávalos-Rodríguez A, Morales-Serna JA, Chávez-García R, Contreras-Ramos A.   +11 more
europepmc   +1 more source

Ventricular, Simulation Of Hypertrophy In Rat Left

, 2016
Ventricular, Simulation Of Hypertrophy In Rat Left
core  

SGLT2 Inhibitors and Cardiovascular Outcomes in Patients With Fabry Disease: Observations From a Federated Research Network

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background and Aim Fabry disease (FD) is frequently complicated by renal impairment and cardiovascular events; however, evidence on sodium–glucose cotransporter‐2 inhibitors (SGLT2i) in this population is scarce. Accordingly, we assessed the association between SGLT2i exposure and cardiovascular outcomes in adults with FD. Methods We conducted
Leandra Serio, Michele Rossi, Amir Askarinejad, Enrico Tartaglia, Tommaso Bucci, Enrica Marrone, Dinesh K. Kalra, Claudio Ferri, Gregory Y. H. Lip   +8 more
wiley   +1 more source

Deep septal pacing and subsequent individualized interventricular electrical optimization in HCM with preserved ejection fraction and high anticipated pacing burden: a case report. [PDF]

Front Cardiovasc Med
Konuş AH.
europepmc   +1 more source

Light Chain Monoclonal Gammopathy of Undetermined Significance: Diagnosis, Biology, and Clinical Management

European Journal of Haematology, EarlyView.
ABSTRACT Light chain monoclonal gammopathy of undetermined significance (LC‐MGUS) is defined by an abnormal serum free light chain ratio and elevated involved light chain in the absence of a detectable immunoglobulin heavy chain on immunofixation and of end‐organ damage attributable to a plasma cell disorder.
Sigurður Yngvi Kristinsson, Thórir Einarsson Long, Sigrún Thorsteinsdóttir   +2 more
wiley   +1 more source

Apical Hypertrophic Cardiomyopathy Mimicking Wellens Syndrome: A Diagnostic Challenge in a Patient Presenting With Recurrent Angina. [PDF]

Cureus
Rodríguez Sánchez MA, Jacobo García JJ, Ayon Martinez JA, Solorio Armenta IN, Mercado Heredia Y, Barrios Angulo AN, Castillo Fuentes M.   +6 more
europepmc   +1 more source

Chd4 and ThPOK cooperate to preserve structural and electrophysiological integrity of the adult heart through Sprr1a repression

The FEBS Journal, EarlyView.
Chd4/NuRD and ThPOK cooperate to maintain transcriptional repression and nuclear organization in adult cardiomyocytes. Chd4 loss reduces miR‐150‐5p, relieving repression of Sprr1a, while ThPOK loss further enhances Sprr1a activation, possibly through altered chromatin–lamina interactions.
Fadoua El Abdellaoui‐Soussi, Apolonia Novillo, Rocío Brea, Marta Ysbert, Lorena Cussó, Gonzalo Pizarro‐Sánchez, Manuel Desco, Iván Hernández, Ángel Luis Armesilla, Ignacio Pérez de Castro, Alicia R. Folgueras, Juan Miguel Redondo, Pablo Gómez‐del Arco   +12 more
wiley   +1 more source

Electrophysiological Markers in Hypertrophic Cardiomyopathy: Enhancing Sudden Cardiac Death Risk Prediction with Index of Cardiac Electrophysiological Balance and Its Corrected Variant. [PDF]

Anatol J Cardiol
Balaban İ, Tanyeri S, Karaduman A, Kültürsay B, Gültekin Güner E, Keten MF, Efe SÇ, Alizade E.   +7 more
europepmc   +1 more source